Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
HAEMATO AG (GB:0VZ7)
LSE:0VZ7
HAEMATO AG (0VZ7) Share Price & Analysis
0 Followers
0VZ7 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€14.99 - €28.00
Previous Close€14.99
Volume0.00
Average Volume (3M)7.46K
Market Cap
€87.53M
Enterprise Value€62.41M
Total Cash (Recent Filing)€29.86M
Total Debt (Recent Filing)€4.73M
Price to Earnings (P/E)8.1
Beta-0.20
Next Earnings
May 20, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jul 19, 2023Dividend Yield7.14%
Share Statistics
EPS (TTM)1.84
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume7,456
Standard Deviation0.10
R-Squared0.03
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
HAEMATO AG News
0VZ7 FAQ
What was HAEMATO AG’s price range in the past 12 months?
HAEMATO AG lowest share price was €14.99 and its highest was €28.00 in the past 12 months.
What is HAEMATO AG’s market cap?
Currently, no data Available
When is HAEMATO AG’s upcoming earnings report date?
HAEMATO AG’s upcoming earnings report date is May 20, 2024 which is in 18 days.
How were HAEMATO AG’s earnings last quarter?
Currently, no data Available
Is HAEMATO AG overvalued?
According to Wall Street analysts HAEMATO AG’s price is currently Overvalued.
Does HAEMATO AG pay dividends?
HAEMATO AG pays a Annually dividend of €1.2 which represents an annual dividend yield of 7.14%. See more information on HAEMATO AG dividends here
What is HAEMATO AG’s EPS estimate?
HAEMATO AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HAEMATO AG have?
HAEMATO AG has 5,229,307 shares outstanding.
What happened to HAEMATO AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of HAEMATO AG?
Currently, no hedge funds are holding shares in GB:0VZ7
---
Company Description
HAEMATO AG
HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.
---
0VZ7 Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 0VZ7
1 Year
1 Year Success Rate
3/10 ratings generated profit
1 Year Average Return
-7.39%
reiterated a buy rating 5 months ago
Copying Christian Ehmann's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of -7.39% per trade.
---